Takeda settles antitrust lawsuit over gout drug Colcrys after trial kicked off

The Japanese pharma giant has inked a settlement with drug wholesalers who accused the company of using anti-competitive deals to delay generic entry to its gout drug Colcrys, a court filing shows.